Dr. Karen Reckamp of City of Hope Cancer Center reviews the concept of acquired resistance to targeted therapies in patients with a driver mutation and why it occurs.

[powerpress]

[ratingwidget post_id=0]

Please feel free to offer comments and raise questions in our Discussion Forums.